Slightly better: Xgeva (denosumab) does have some advantages over zometa: quicker administration and no kidney side effects. It is associated with fewer bone complications from cancer than zometa. On the other hand, zometa is now generic, meaning that is a lot cheaper. Neither is a curative treatment for prostate cancer and they are both considered adjunct treatments. Thes small differences may or may not justify its use.
Answered 5/11/2016
5.4k views
Xgeva (denosumab): Zolmera can have more side effects, that is my view.
Answered 5/6/2013
5.2k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
9 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question